Skip to content

Clinical trials

Hypersensitivity trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypersensitivity Country / region: Australia Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20101
20131
20141
20151
20171
20181
20201
20214
20222
20241
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting5
Active, not recruiting2
Terminated2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Murdoch Childrens Research Institute4
Celgene2
Cogent Biosciences, Inc.2
DBV Technologies2
Ellodi Pharmaceuticals, LP2
Diag-Nose Medical Pty Ltd1
Faes Farma, S.A.1
GlaxoSmithKline1
Novartis Pharmaceuticals1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypersensitivity21
Immune System Diseases5
Eosinophilia4
Eosinophilic Esophagitis4
Esophageal Diseases4
Esophagitis4
Gastroenteritis4
Gastrointestinal Diseases4
Hematologic Diseases4
Eczema3

Trials

Showing 76 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.